Roivant Sciences Ltd. (ROIV) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2026 | -$750.35M | +10.6% |
| 2025 | -$839.45M | -9.7% |
| 2024 | -$765.27M | +9.3% |
| 2023 | -$843.39M | -24.4% |
| 2022 | -$677.73M | -22.7% |
| 2021 | -$552.14M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2026 | -$750.35M | +10.6% |
| 2025 | -$839.45M | -9.7% |
| 2024 | -$765.27M | +9.3% |
| 2023 | -$843.39M | -24.4% |
| 2022 | -$677.73M | -22.7% |
| 2021 | -$552.14M | — |